Pharm Review Flashcards
Pharmacokinetics
Absorption
Distribution
Metabolism
Excretion
Pharmacodynamics
- dose response and maximal efficacy
- onset/peak/duration
- receptor theory
- agonist vs antagonists
Categories of drug action
- Stimulation or depression
- replacement
- inhibition or killing of organisms
- irritation
Loafing dose
A large initial dose to achieve an immediate response of a drug
Therapeutic dose
A safe range dosing for a patient that is effective for them
Safe vs toxic dose
Therapeutic index=LD/ED
- the closer the number is to 1, the greater the danger of toxicity
MEC
Minimum effective concentration
Antagonist
Drugs that block a response
Agonist
Drugs that produce a response
Additive
An effect in which two substances or actions used in combination produce a total effect the same as the sum of the individual effects
Synergistic
Enhancing the effect of another force or agent
Side effects
Physiologic effects not related to desired drug effects. Can be desirable, or undesirable
Adverse effects
More severe than side effects, they are unintended effects of drugs
- always undesirable
1st gen. NSAIDS
-Toradol,Motrin,
-can inhibit both COX-1 and COX-2 inhibitors
SE:gastric irritation
2nd gen. NSAIDS
Can inhibit just COX-2
Controlled substance schedule
Scale of 1-5
-1 being the most addictive and have no medical use in United States to five which have low potential for addiction
Category A
No risk to fetus, studies have not shown evidence of fetal harm
Category B
No risk in animal studies, and well controlled studies in pregnant women are available
-it is assumed there is little to no risk to fetus
Category C
Animal studies indicate a risk to the fetus, controlled studies on pregnant women are not available
- risk vs benefit must be determined
Category D
A risk to the human fetus has been proved
- risk vs benefit must be determined
- can be used in life threatening conditions
Category X
A risk to the human fetus has been proved
-risk outweighs benefit and drug must be avoided
Phase 1
Look at med in healthy people
Phase 2
Look at med in small population of people with disease
Phase 3
Look at ethnic groups